Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : HONG KONG -- Ignore unavailable to you. Want to Upgrade?

To: Richard Tsang who wrote (1033)	12/31/1997 11:36:00 AM
From: Michael Bakunin	Read Replies (1) \| Respond to of 2951

Jardine delisted itself, I thought. An old hong, they decided, some years back, that listing in Bermuda and Singapore would provide a little distance from 1997, over which people were pretty concerned for a while. They're an old-fashioned conglomerate, with many holdings, and through their many subsidiaries end up being the biggest landlord in HK, as well as the largest single employer. I like the company and the stock, these days. The company's has been around for a while. They're trying to trim less profitable businesses, and though their results have been underwhelming for a little while, they still do fine. The stock is cheap, as mentioned, albeit with the caveats that apply to any company so heavily involved with Asia these days. Check out their web site @ jardine-matheson.com

To: Richard Tsang who wrote (1033)	1/1/1998 5:32:00 PM
From: ----------	Read Replies (1) \| Respond to of 2951

Richard: As I understand it, Jardine Matheson is a conglomerate holding company with global operations. While this is an over simplification, it is more of a "global fund" than a HK/China specific investment. Some of their subsidiaries, (E.G. The Jardine Fleming group), are more HK/China specific. I know very very little about them, and have nothing against them. But, I already own shares in Templeton Dragon Fund, (NYSE: TDF). I bought the shares at @ 18% discount to NAV, and the fund is managed by Dr. Mark Mobius. I do know Dr. Mobius' record, his philosophy and the years he spent as John Templeton's understudy. That does not necessarily make him or his fund any better than anyone else's. It does allow me to rest comfortably, as I personally have a high degree of confidence in Dr. Mobius. Sorry I could not be of more assistance. Doug